Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

BACKGROUND: To evaluate the efficacy of highly-active antiretroviral therapy (HAART) in individuals taking cytochrome P450 enzyme-inducing antiepileptics (EI-EADs), we evaluated the virologic response to HAART with or without concurrent antiepileptic use. METHODS: Participants in the US Military HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Okulicz, Jason F, Grandits, Greg A, French, Jacqueline A, George, Jomy M, Simpson, David M, Birbeck, Gretchen L, Ganesan, Anuradha, Weintrob, Amy C, Crum-Cianflone, Nancy, Lalani, Tahaniyat, Landrum, Michael L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119192/
https://www.ncbi.nlm.nih.gov/pubmed/21575228
http://dx.doi.org/10.1186/1742-6405-8-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119192/
https://www.ncbi.nlm.nih.gov/pubmed/21575228
http://dx.doi.org/10.1186/1742-6405-8-18

Ejemplares similares